Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Dexcom (DXCM) over the last 13 years, with Q4 2025 value amounting to $0.67.

  • Dexcom's EPS (Weighted Average and Diluted) rose 7631.58% to $0.67 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.09, marking a year-over-year increase of 4615.38%. This contributed to the annual value of $2.09 for FY2025, which is 4718.31% up from last year.
  • Latest data reveals that Dexcom reported EPS (Weighted Average and Diluted) of $0.67 as of Q4 2025, which was up 7631.58% from $0.7 recorded in Q3 2025.
  • Over the past 5 years, Dexcom's EPS (Weighted Average and Diluted) peaked at $0.7 during Q3 2025, and registered a low of -$0.01 during Q4 2021.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $0.29 (2023), whereas its average is $0.33.
  • Per our database at Business Quant, Dexcom's EPS (Weighted Average and Diluted) tumbled by 7123.29% in 2021 and then surged by 230000.0% in 2022.
  • Over the past 5 years, Dexcom's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.01 in 2021, then soared by 2300.0% to $0.22 in 2022, then surged by 177.27% to $0.61 in 2023, then plummeted by 37.7% to $0.38 in 2024, then surged by 76.32% to $0.67 in 2025.
  • Its last three reported values are $0.67 in Q4 2025, $0.7 for Q3 2025, and $0.45 during Q2 2025.